NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a publicly traded Healthcare sector company. As of May 20, 2026, NAMS trades at $35.77 with a market cap of $3.99B and a P/E ratio of -20.07. NAMS moved +6.11% today. Year to date, NAMS is +6.78%; over the trailing twelve months it is +84.75%. Its 52-week range spans $14.06 to $42.21. Analyst consensus is strong buy with an average price target of $48.00. Rallies surfaces NAMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NAMS moved +6.11% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $35.77 |
| Market Cap | $3.99B |
| P/E Ratio | -20.07 |
| EPS | $-1.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.21 |
| 52-Week Low | $14.06 |
| Volume | 1.15M |
| Avg Volume | 0 |
| Revenue (TTM) | $22.57M |
| Net Income | $-212.73M |
| Gross Margin | 0.00% |
11 analysts cover NAMS: 0 strong buy, 10 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.00.